207_Combined course Presentations

A colleague has referred to you a 62 year old male patient in excellent clinical conditions (ECOG PS 0) affected with LD-SCLC. No comorbities. Which is the best treatment strategy for this patient ?

A.

Chemotherapy alone (Cisplatin +

Etoposide x 4-6 cycles)

B.

Chemotherapy (Cisplatin + Etoposide)

+ thoracic RT (60 Gy)

C.

Chemotherapy (Cisplatin + Etoposide x

4 cycles) + thoracic RT (60 Gy) +

Prophylactic cranial irradiation if

patients responds to CMT.

D.

Chemotherapy (Cisplatin + Paclitaxel x

4 cycles) + thoracic RT (60 Gy) +

Prophylactic cranial irradiation if

patients responds to CMT.

Made with